Abstract -Mutations in the myostatin gene lead to double-muscling in cattle indicating that it is a negative regulator of the total number of muscle fibres. Myostatin expression was analysed by RT-PCR in three developing bovine muscles. It decreased during differentiation in Semitendinosus and Biceps femoris, and increased in the late differentiating Masseter during gestation. A combination of in situ hybridisation and immuno-histochemical detection of myosin heavy chains (MHC) allowed us to locate the expression in myofibres containing only developmental MHC at different stages and in fast IIA fibres at the end of gestation. In vitro, myostatin was undetectable during proliferation, peaked at the onset of fusion and decreased during terminal differentiation. It was not detected in myotubes by in situ hybridisation. The inhibition of differentiation by BrdU prevented the decrease in expression. Our results show that the peak in myostatin expression coincides with early differentiation indicating a regulatory role in cattle myogenesis. myostatin [GDF8] / cattle / myogenesis / myoblast culture / in situ hybridisation
INTRODUCTION
Myostatin (Growth/Differentiation Factor-8, GDF-8) is a member of the Transforming Growth Factor β superfamily [1] . Based on sequence homologies, myostatin shares structural features with the members of the family. It is produced as a precursor form that is proteolytically processed as are the other members of the superfamily. The bioactive form is probably a disulfidelinked dimer of the C-terminal domain [1] .
Myostatin is highly conserved among species. Predicted proteins in humans, rats, mice, pigs and chicken exhibit 100% homology in their bioactive domain, whereas there is a 3 amino-acid difference in the mature sequence [2] .
Transgenic mice lacking the myostatin gene exhibit enlarged skeletal muscles related to an increase in the number (hyperplasia) and in the area (hypertrophy) of the muscle fibres [2] . Double-muscling (DM) in cattle is also characterised by a greater muscle mass due primarily to hyperplasia [3] . Interestingly, DM animals display mutations in their myostatin gene [2, 4, 5] corresponding to the previously identified mh locus [4, 6] . These mutations lead to the production of an inactive peptide. For example, in the DM Belgian Blue breed systematically selected for double-muscling, an 11-bp deletion has occurred in the third exon in a region encoding the bioactive domain, generating a truncated inactive carboxy-terminal domain [2, 5, 7] . An increase in the total number of muscle fibres in double-muscling has been observed as early as the foetal period [8] . Cultured DM myoblasts display an increased proliferation thus supporting the latter [9, 10] . The combination of these data supports the hypothesis that myostatin acts as a negative regulator of muscle growth. In vitro studies have shown that recombinant myostatin reversibly inhibits myoblast proliferation [11] [12] [13] . Thomas et al. [13] have proposed a role for myostatin in the induction of myoblast withdrawal from the cell cycle, via an increase in cyclin-dependant kinase inhibitor p21 expression and a decrease in Cdk2 proteins and activity. Recently, in vitro experiments have also provided evidence that extra myostatin impairs C2C12 myoblast differentiation [14, 15] , through the inhibition of MyoD1 expression and activity [14] .
Myostatin is predominantly expressed in skeletal muscle. It has also been described in mouse adipose tissue [1] , in mouse and sheep heart [16] and in sow mammary glands [17] . Its expression has been detected very early in the muscle of developing mice [1] , cattle [7] , pigs [17] and chicken [18] . It is decreased but just maintained after birth in skeletal muscles [1, 7, 19] . In the adult, muscle atrophy caused by hindlimb unloading is associated with increased myostatin expression [20] [21] [22] . Conversely, it has been shown that its expression is decreased during the early stages of muscle regeneration after injury [21, 23, 24] . The aim of this study was to follow the kinetics of myostatin expression during bovine muscle myogenesis in vivo and in vitro by RT-PCR. Moreover, it allowed us to identify the myostatin-expressing cells by combining in situ hybridisation and immuno-histochemical techniques.
MATERIALS AND METHODS

Animals
The study was carried out as a part of a research programme approved by the "Institut National de la Recherche Agronomique" (INRA, France) Ethical Committee. The cows were bred and slaughtered, and foetuses were collected, according to ethical guidelines concerning animal care. For the in vivo study 20 Charolais foetuses were produced by artificial insemination. Four foetuses were collected at 90, 110, 180, 230 and 260 days post-conception (dpc). Their Masseter (MA), Biceps femoris (BF) and Semitendinosus (ST) muscles were dissected and snap-frozen. For in vitro studies, four Holstein foetuses (tested for the absence of a myostatin mutation) were produced by artificial insemination. They were collected at the gestational age of 100 days, corresponding to a period of intense proliferation of the second myoblast generation [25] .
Cell Cultures
Primary cultures of foetal myoblasts were performed according to Picard et al. [10] . Briefly, foetal skeletal muscles from the hindlimbs were dissected under sterile conditions. They were cut into small cubes in Dulbecco Modified Eagle Medium (DMEM; GibcoBRL, Life Technologies, France). Three incubations with 0.25% trypsin (GibcoBRL, Life Technologies, France) for 20 min allowed the cells to dissociate. After the first incubation, the sus pension (essentially composed of fibroblasts) 528 V. Deveaux et al. was used for seeding fibroblast cultures.
Fibroblasts were plated at a density of 10 4 cells/cm 2 in 100-mm dishes. After the next two digestions, trypsin was removed by centrifugation of the cell suspension at 900 g for 10 min. Pelleted cells were then suspended in DMEM supplemented with 0.2 mM L-Glutamin, 5 µg·mL -1 gentamycin and 10% foetal calf serum (FCS; Sigma Aldrich, France). After 30 min pre-plating at 37 o C, the cells were plated at a density of 2.10 4 cells/cm 2 in 100-mm dishes for mRNA studies. Labtek chamber slides (Nunc, Denmark) were used for in situ hybridisation studies. In order to study the influence of an inhibition of myogenic differentiation, some cultures were treated by 5 µg·mL -1 of 5-bromo-deoxyuridine (BrdU, [26] ). All cultures were incubated at 37 o C in a 5% CO 2 atmosphere, and were fed fresh medium 24 h after plating.
Primary cultures of normal satellite cells were prepared as described previously [27] . Briefly, the cells were isolated from cultured explants of Longissimus thoracis muscle derived from adult cows. They were seeded at a density of 10 4 cells/cm 2 in 100-mm gelatin-coated dishes and were grown in a feeding medium consisting of a mixture of DMEM and HAM-F12 (vol/vol) and of 15% FCS. At sub-confluence, the cells were shifted to a differentiation medium consisting of 2% Horse Serum in order to favour their differentiation.
RT-PCR
After extraction of total RNA using the thyocianate guanidium method derived from Chomczynski and Sacchi [28] , first strand cDNA was synthesised from 2.5 µg of total RNA using a SUPERSCRIPT ™ II RNase H -reverse transcriptase (GibcoBRL, Life Technologies, France), according to the manufacturer's protocol.
PCR reactions were performed using Taq DNA Polymerase (Promega, France) to monitor myostatin, myogenic regulatory factors and myosin heavy chain expression analyses. The primers were synthesised by Eurobio (France). Primer sequences and cycling conditions are listed in Table I . PCR were performed with 3 µL of the reverse transcription reaction. A fragment of the bovine TATA box-binding protein (TBP) cDNA was amplified to serve as a control for the in vivo studies whereas a fragment of the cyclophilin T cDNA served as a control for the in vitro studies. Statistical analysis confirmed that the expression of the TBP and cyclophilin T genes did not vary significantly during the developmental stages and time-course of culture respectively (data not shown 
In situ hybridisation
The bovine myostatin cDNA was inserted into the pGEM ® -11Zf(+) vector (Promega, France). After linearisation of the plasmid, anti-sense and sense (control) cRNA probes were synthesised respectively using T7 and SP6 RNA polymerase (RiboProbe ® combination system SP6/T7, Promega, France). The probes were labelled with fluorescein-UTP (Roche Diagnostics, France).
Transverse sections of 10 microns thick and cell culture slides were fixed using a 4% paraformaldehyde solution in PBS for 15 min and dehydrated in three successive ethanol solutions (85%, 95% and 100%, 5 min each); then the slides were stored at -80 o C until their utilisation. Hybridisation was performed using the method adapted from Fontaine-Pérus et al. [29] . Briefly, the probes were diluted in ULTRAhyb ™ buffer (Ambion, Clinisciences, France) and were laid on the slides, which were then incubated at 42 o C overnight. After three washes in 1× SSC, 50% formamid and 0.1% Tween-20 solution and two washes in 0.1 M maleic acid, 0.2 M NaOH, 0.15 M NaCl and 1% Tween-20 solution, the slides were treated for 2 hours in 2% Reagent blocking (Roche Diagnostics, France) solution. Then they were incubated with a conjugated anti-fluorescein antibody coupled to alkaline phosphatase (AP) (Roche Diagnostics, France) at room temperature overnight. The revelation of the AP activity was performed with BM purple AP substrate (Roche Diagnostics, France). The slides were then mounted in PBS-glycerol and analysed under an inverted light microscope (Labophot-2, Nikon).
Muscle fibre-type determination
Myosin heavy chain (MHC) isoform content was revealed at development stages by immuno-histochemical staining using the following monoclonal antibodies (MAB) purchased from Biocytex (Marseille, France): MAB S, F36 5B9, specific to slow MHC; MAB R, F113 15F4, specific to fast MHC (MHC 2a and 2b, 2x); MAB F, F158 4C10, specific to foetal MHC; MAB I+IIb+IIx, S5 8H2, specific to both slow and fast 2b and 2x MHC (without any cross-reactivity with 530 V. Deveaux et al. 
Western blot analyses
Cell cultures were homogenised in buffer containing 2% SDS, 10% glycerol, 63 mM Tris pH 6. 
Statistical analysis
Myostatin data were analysed using the GLM procedure [33] in a model that contained TBP expression levels as covariables and the effects of age separately within muscles. Differences in LSMeans between ages were further separated by the PDIFF option. TBP was chosen as a reference gene according to [34] and was used as a covariable rather than a ratio normalisation term in order to avoid statistical bias [35] .
RESULTS
Myostatin expression during in vivo myogenesis
The kinetics of myostatin expression was followed by semi-quantitative RT-PCR during foetal development in three different muscles. The Masseter (MA) was chosen because it is not hypertrophied in DM cattle. Conversely, the Biceps femoris (BF) and the Semitendinosus (ST) muscles were chosen because they are hypertrophied in DM cattle [36] . The temporal pattern of expression differed between muscles. In ST (Fig. 1A) , the expression was high at 110 dpc, decreased between 110 and 180 dpc (P < 0.05), and thereafter did not significantly vary until 260 dpc. In BF (Fig. 1B) , the expression significantly increased between 110 and 180 dpc (P < 0.05) and thereafter decreased (P < 0.05 between 180 and 260 dpc). In MA (Fig. 1C) , myostatin expression gradually increased all through gestation and was significantly higher in the third term than at 110 dpc (P < 0.05 between 110 and 230 dpc, P = 0.01 between 110 and 260 dpc).
The location of myostatin expression in foetal skeletal muscle was possible by combining in situ hybridisation and immunological detection of MHC isoforms on transverse serial sections. In situ hybridisation revealed that myostatin mRNA was mainly located in bundles of fibres and only sparsely in the interstitial tissue (Fig. 2) . Moreover, whatever the developmental stage, only a small proportion of cells expressed myostatin (Fig. 2) . No specific staining was observed with the sense probe (Fig. 2) . At each stage, no myostatin mRNA was detected within the slow MHC-expressing first myogenic generation whose differentiation is most advanced. At 90 dpc (33% of gestation), the myostatin-expressing cells were stained using antibodies raised against developmental α-cardiac and foetal MHC, but not with those raised against adult slow and fast MHC (Fig. 3A) .
The myostatin-expressing cells were small cells corresponding to the second myogenic generation according to Picard et al. [30] . At 180 dpc (66% of gestation), the expression was also located in the less differentiated cells (Fig. 3B) characterised by a restricted expression of developmental MHC as in the preceding stage [30] . At 260 dpc (96% of gestation), the myostatin-expressing cells no longer contained any developmental MHC but were positive for adult fast MHC. An antibody recognising both slow and fast (2b, 2x but not 2a) MHC did not stain the myostatinexpressing cells. According to Picard et al. [37] , these fibres were identified as IIA fibres (Fig. 3C) . 
Myostatin expression during in vitro myogenesis
In a second study, we investigated myostatin expression in primary myoblast cultures isolated from 100-day-old normal foetuses. The cells proliferated for 3 days until they aligned at confluence and began to fuse into myotubes. The cells were harvested at these different stages and total RNA was prepared for RT-PCR analysis of myogenic markers. MyoD and Myf-5 were expressed early during the culture, starting with the proliferation phase. Their expression Myostatin expression during bovine myogenesis 533 was maintained until confluence/onset of fusion (Fig. 4) . Neither factor was expressed any longer during differentiation (Fig. 4) . Myogenin was expressed from the beginning of fusion and during differentiation (Fig. 4) . MRF4 began to be slightly expressed at the onset of fusion and was expressed at the highest level during differentiation (Fig. 4) . Expression of slow and fast 2a MHC began with the confluence/onset of fusion (Fig. 4) and increased during differentiation (Fig. 4) . The detection and time-course of myogenic specific marker expressions confirmed that our primary cultures were mainly constituted of myogenic cells (90% of Myf-5-expressing cells, data not shown). As expected, none of these markers was expressed in control fibroblast cultures (Fig. 4) .
We could not detect any myostatin expression by Northern blot analysis, except at cell confluence (data not shown). Thus, myostatin expression was followed by RT-PCR (Fig. 5A ). Myostatin mRNA was first detected in confluent cultures before the formation of myotubes and concomitantly with myogenin mRNA (Fig. 5A) . In differentiating cells, myostatin expression was markedly decreased but remained detectable by RT-PCR (Fig. 5A) . Myostatin expression was also found in differentiating bovine satellite cells, isolated from adult muscles. Myostatin expression, similar to myogenin expression, was undetectable during proliferation and was up-regulated once the cells had been switched to a differentiation medium (Fig. 5A) . Interestingly, Myostatin mRNA was not detected by RT-PCR in muscle fibroblast cultures (Fig. 5A) clearly indicating that the expression was restricted to myogenic cells. As expected, no differences were detected in the housekeeping gene cyclophilin T levels of expression.
In situ hybridisation experiments confirmed the temporal pattern of myostatin expression in foetal myoblast cultures. During proliferation, only a few cells weakly expressed myostatin (Fig. 5B) . At sub-confluence, a high percentage of mononucleated cells was positive for myostatin mRNA (Fig. 5B) . The staining was more intense indicating a higher level of expression. In differentiating cultures, myostatin expression was located in a few mononucleated cells and was not detected in myotubes (Fig. 5B) . No staining was detected with a myostatin sense probe demonstrating the specificity of the hybridisation (Fig. 5B) . Thus, myostatin expression was restricted to non-fused cells in primary myoblast cultures. This finding indicated that it was closely linked to the differentiation state of the cells.
In order to test if the fall in myostatin expression was a consequence of myoblast differentiation, we induced experimental inhibition of myoblast fusion. The cells were treated with 5 µg·mL -1 of BrdU and compared to control cells grown in the absence of BrdU. The cells were harvested at confluence/onset of fusion, 24 h after confluence and differentiation respectively (Fig. 6A) . The proteins and total RNA were prepared from the cultures. As expected, myoblast 536 V. Deveaux et al. fusion was inhibited in BrdU-treated cells (Fig. 6B) . The inhibition of differentiation was shown by the low accumulation of myogenin and desmin proteins (two markers of differentiation [10, 38] ) in BrdU-treated cells compared to control cells whatever the stage (Fig. 6C) . Interestingly, myostatin expression was higher in BrdUtreated than in control cells at confluence (Fig. 6D) . This was still observed 24 h later and at a stage corresponding to differentiation in control cultures (Fig. 6D) . Thus, the inhibition of myoblast fusion induced the maintenance of a high level of myostatin expression. These results strongly suggest that the decrease in expression observed during differentiation occurred following fusion and/or the onset of differentiation.
DISCUSSION
In this study, with a combination of RT-PCR and in situ hybridisation data we showed that myostatin expression is differentially regulated in developing muscles according to their kinetics of differentiation. We also found myostatin expression in myogenic cells corresponding to the less differentiated cells in vivo and in vitro. In particular, this expression was associated with fast IIA fibres at the end of gestation.
Differential expression between developing muscles according to their differentiation status
As in the report of Oldham et al. [39] , myostatin expression in ST was high at 110 dpc, decreased thereafter, and was maintained at lower levels during the last trimester of gestation. Different kinetics of expression was observed in BF and MA compared to ST muscle. A peak in expression was detected at the end of the second gestation trimester (180 dpc) in BF. During the last trimester, the expression level was gradually restored to the one measured at 110 dpc. Conversely the expression steadily increased in MA during gestation and was higher at the end-term than at 110 dpc. Differences in the temporal pattern of myostatin expression may rely on the differential precocity of the muscles. In cattle, proliferation of muscle cells occurs during the first two trimesters of gestation, whereas their contractile and metabolic differentiations occur in the last trimester [25, 40] . However, muscles display a variability in the kinetics of differentiation. In particular, BF and MA differentiate later than ST muscle [25] . Interestingly, lower myostatin expression during the last trimester coincides temporally with the acquisition of contractile and metabolic properties of fibres in ST and BF. A decrease in myostatin expression with differentiation has also been reported in other species. In the chicken, it decreases at hatching [18] when the number of fibres is fixed [41] . In the pig, the highest level of expression detected before birth [17] also coincides with a fixed number of cells just after birth [42] .
We confirmed the fall of myostatin expression along with the fusion and differentiation process in vitro. In cultured bovine myoblasts, no myostatin transcript was detectable in growing cells before differentiation started. We detected a transient peak of myostatin mRNA at the end of the proliferation phase. Myostatin expression was found in confluent cultures, e.g. before myoblast fusion and the appearance of myotubes. Several studies have described a similar expressional pattern respectively in chicken satellite cells and C2C12 myoblasts [11, 24, 43] . However, as in our satellite cell cultures, myostatin up-regulation was observed in C2C12 when fusion was already established [24] . Satellite cell cultures allowed us to confirm that the onset of myostatin expression was detected in post-mitotic cultures as shown by myogenin expression [10] . Unfortunately, we could not technically identify which type of cells (mononucleated vs. myotubes) expressed myostatin. Since foetal myoblasts and satellite cells constitute distinct myogenic populations, this may account for the observed differences in their onset of myostatin expression. In particular, they display differences in their kinetics of titin, desmin and MHC accumulation [10, 27] . Moreover, the differentiation of satellite cells requires a switch to a differentiation medium which appears to delay the time-course of differentiation and the onset of myogenin expression compared to cultured foetal myoblasts.
As observed for MyoD and Myf-5 expression, myostatin expression decreased during terminal differentiation of foetal myoblasts and remained barely maintained. The expression was preserved when the fusion and terminal differentiation had been inhibited by BrdU. According to the finding that fusion-defective BC 3 H 1 myocytes express myostatin under differentiation conditions [24] , our results show that fusion is not a prerequisite for myostatin expression. Moreover, they indicate a link between the differentiation process and the decrease in myostatin expression. The fall of myostatin transcripts may occur consecutively to myogenin/MRF4 up-regulation and/or MyoD/Myf5 down-regulation during terminal differentiation. Myogenic transcription factor binding sites (E-boxes) have recently been found in the bovine myostatin promoter [44] indicating that the gene is at least a downstream target of MyoD1. However, in our differentiating cultures, myostatin levels were decreased in spite of high myogenin levels. Conversely, high myostatin levels were detected in spite of a decrease in myogenic factors induced by BrdU. All together, these results suggest that these E-boxes may not have a major role in the induction or maintenance of myostatin expression during terminal differentiation.
The location of myostatin expression within the less differentiated cells
Using in situ hybridisation and immunohistochemistry, we assigned myostatin expression within muscle bundles specifically to myogenic cells. We never observed myostatin expression in the first generation of differentiated myofibres at the stages we studied. However, myostatin may be expressed in the first generation at previous stages since expression has been found as early as in 30 dpc in bovine muscles [7] corresponding to the appearance of the first generation of myotubes. An explanation for the absence of detection of mRNA within the first generation can be that primary fibres are the most advanced in their differentiation at the stages we studied. In particular, differentiation is completed at 180 dpc [25, 40] . At 90 and 180 dpc, expression in ST was restricted to myotubes containing developmental MHC but not any adult MHC. At the end of gestation, myofibres positive for myostatin expression were fast IIA myofibres arising from the third generation. At this stage, IIA fibres contain a higher proportion of developmental MHC than I and IIX fibres and therefore are less differentiated [42] . From these results, myostatin expression appears to be restricted to the less differentiated myofibres at each developmental stage [42] . Thus, the decrease in myostatin expression during development may be related to the progressive maturation of myofibres of the second and third generations. This may explain why the level of expression was decreased earlier in ST than in the other muscles. In contrast, in MA in which differentiation is the latest and is not completed at birth [25] , the highest myostatin expression was found at the end of gestation. Interestingly, this muscle also contains a high proportion of IIA fibres at this stage [25, 45] as compared to the others.
Contradictory data have been reported among species about the fibre type location of myostatin expression. In humans and in chickens, there is no difference between fast and slow muscles in terms of their myostatin expression in vivo and in vitro [43, 46] . In rodents, myostatin mRNA and protein levels are higher in fast than in slow muscles [20, 22] . In agreement with the l 538 V. Deveaux et al. e latter, we found that myostatin expression was localised within the fast fibres. However, Carlson et al. [20] demonstrated a significant positive regulation between MHC 2b content and myostatin mRNA abundance in normal muscle in mice. They hypothesised that muscle fibre type-specific gene expression could be modulated by myostatin and that myostatin may act to positively reinforce the fast phenotype. Unlike them, we showed that myostatin expression was associated with IIA fibres and we did not detect it in IIX fibres. The observation that myostatin was expressed within the less differentiated cells in vivo was confirmed in vitro. In contrast with Artaza et al. [47] who located MSTN protein mostly in differentiated C2C12 myotubes, we found myostatin mRNA only in a few mononucleated cells and not in terminally differentiated myotubes in differentiating cultures. However, we cannot exclude that myostatin could be transiently expressed in early myotubes and that we have not detected it at the stages analysed in vitro. This would provide an explanation to the detection of expression within myofibres in vivo. Because no myostatin mRNA was detected in confluent muscle fibroblast cultures, and 90% of the cells were positive for Myf-5 at seeding, we can conclude that myostatin-expressing cells are mostly myogenic. These cells may constitute either myoblasts withdrawing late from the cell cycle and entering the differentiation process, or undifferentiated myoblasts protected from apoptosis [48] . The apparent contradiction between our results and those of Artaza et al. [47] may also be explained by the observation that the myostatin protein levels do not follow the changes of their transcripts and increase, whereas mRNA decrease during regeneration [24] . In such a hypothesis, in situ myostatin synthesis may increase in myotubes along with differentiation. Immunocytochemical detection of myostatin protein in our cultures may provide further elements to support this proposal.
Physiological significance of the myostatin expression-window
In this study, we observed that in developing bovine muscles, myostatin is expressed in a spatial and temporal sequence controlling their fibre numbers and terminal differentiation. Moreover, it is transiently expressed at the onset of differentiation in cultured myoblasts derived from foetal muscles. Based on these observations, myostatin appears to play a crucial role in the transition between proliferation and differentiation. Several studies have reported that myostatin acts as an inhibitor of proliferation [11] [12] [13] . It has also recently been shown that this factor inhibits myogenic differentiation in vitro [14, 15] and in vivo [49] by down-regulating the expression of transcription genes associated with myogenic differentiation such as MyoD1. However, a recent study has demonstrated that endogenous myostatin does not exert its inhibitory influence through the regulation of myoD1 expression [48] but through down-regulation of myogenic RNA and protein levels. Thus, myostatin is suspected to control myoblast numbers in the developing muscles by negatively regulating both their proliferation and differentiation although through distinct molecular pathways [50] as confirmed in vitro [13, 14] . In DM cattle, production of a non-functional protein could be responsible for the deregulation of the myoblast proliferation/differentiation process subsequently leading to (1) an increase in the myoblast pool resulting in fibre hyperplasia, and (2) increased myogenesis resulting in hypertrophic muscle masses. However, there is a discrepancy with the observation that differentiation is delayed both in vivo and in vitro in DM animals [10, 51] .
